Showing results (161-170 of 229) with videos related to

Sort By:
Pageof 23
JCO Precision Oncology|March 12, 2019
Genomic Characterization of Upper-Tract Urothelial Carcinoma in Patients With Lynch SyndromeTimothy F Donahue, Aditya Bagrodia, François Audenet, et al.
Human Mutation|August 25, 2019
Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinomaLiying Zhang, Michael F Walsh, Sowmya Jairam, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 14, 2020
A Multi-Institutional Cohort of Therapy-Associated Polyposis in Childhood and Young Adulthood Cancer SurvivorsLeah H Biller, Chinedu Ukaegbu, Tara G Dhingra, et al.
Cancer|January 17, 2018
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinomaEileen M O'Reilly, Jonathan W Lee, Maeve A Lowery, et al.
NPJ Precision Oncology|November 19, 2025
Paired tumor-normal sequencing provides insights into the CDKN2A-associated tumor spectrumKelsey E Breen, Nikita Mehta, Vignesh Ravichandran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing PanelsZsofia K Stadler, Francesca Battaglin, Sumit Middha, et al.
JAMA Oncology|March 23, 2018
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal CancerAndrea Cercek, Campbell S D Roxburgh, Paul Strombom, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 21, 2019
Changes in the multidisciplinary management of rectal cancer from 2009 to 2015 and associated improvements in short-term outcomesC S D Roxburgh, P Strombom, P Lynn, et al.
Cancer|November 23, 2016
Clinical and genetic determinants of ovarian metastases from colorectal cancerKaruna Ganesh, Ronak H Shah, Efsevia Vakiani, et al.
Clinical and Translational Medicine|May 29, 2025
Responsiveness of different MET tumour alterations to type I and type II MET inhibitorsYonina R Murciano-Goroff, Valentina Foglizzo, Jason Chang, et al.
Pageof 23